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Case Report 
Mesenteric Castleman’s Disease: Case Report and
Literature Review
Said Al-Natour, Samer Sawalhi, Danna Al-Muhtady and Eman Hijazi1,
Department of Surgery and 1Department of Pathology, Islamic Hospital, Amman, Jordan.
A 41-year-old man was discovered to have a pelvic mass during investigation for hypertension 2 years ago.
Otherwise, he was asymptomatic, and abdominal magnetic resonance imaging revealed a highly vascular
solid mass superior to the urinary bladder. A 131I-meta-iodobenzylguanidine whole body scan was
reported as normal, which ruled out the possibility of extra-adrenal pheochromocytoma. No definitive
preoperative diagnosis could be established. Surgical resection of the tumour revealed mesenteric
Castleman’s disease, hyaline vascular type. Such a diagnosis should be considered for any abdominal 
vascular mass. [Asian J Surg 2010;33(3):150–3]
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Introduction
Castleman’s disease (CD) is a giant lymph node hyperpla-
sia or angiofollicular lymphoid hyperplasia of unknown
origin,1 which has attracted attention because of its asso-
ciation with human immunodeficiency virus (HIV) and
human herpes virus 8 (HHV8).2 The disease was first
described by Castleman in 1954,3 and in the majority of
the reported cases, the disorder is located in the medi-
astinum, whereas mesenteric involvement is very unusual.1
The neck, retroperitoneum, pancreas, pelvic cavity and
axillary and inguinal lymph nodes are also reported sites
of involvement.
It is associated with a number of malignancies, includ-
ing Kaposi’s sarcoma, non-Hodgkin’s lymphoma, Hodgkin’s
lymphoma and POEMS syndrome (polyneuropathy,
organomegaly, endocrinopathy, M-protein, skin manifes-
tation). It is encountered in patients aged between 30 and
40 years and rarely occurs in children.2 CD should be
included in the differential diagnosis of every mass
located in the mesentery. In the present case, the final
diagnosis was established after explorative laparotomy
and resection of the tumour. To the best of our knowl-
edge, only 23 cases of mesenteric Castleman’s disease have
been reported in the English-language literature.3
Case report
A 41-year-old man with hypertension presented to the
outpatient clinic with a history of lower abdominal mass
(6 cm × 7 cm) (Figure 1) that was discovered incidentally
two years earlier upon investigations for hypertension.
Colonoscopy was performed twice over 2 years on both
occasions. There was a pressure effect on the rectum with-
out any mucosal abnormality, and he was advised to have
the abdominal mass resected, but he refused. The patient
was asymptomatic with a normal appetite, no vomiting
or abdominal pain, with regular bowel habits and no
weight changes. He had no urinary, respiratory or cardio-
vascular symptoms, no constitutional symptoms, had not
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undergone previous surgery. He was not a smoker and his
only medication was antihypertensive drugs (amlodipine
and carvedilol).
Upon physical examination, his blood pressure was
150/90 mmHg; he had suprapubic fullness of about
10 cm × 10 cm with a smooth surface, which was nonpul-
satile, firm in consistency and relatively immobile; other-
wise his examination was unremarkable. Abdominal
magnetic resonance imaging revealed a large heteroge-
neous solid mass superior to the urinary bladder, which
measured about 7 cm × 8 cm × 9 cm in maximum dimen-
sion (Figures 2A and 2B). The mass showed avid enhance-
ment with intravenous contrast agent and multiple
necrotic foci. The mass appeared to be vascular, and took
multiple branches from the right common iliac artery. 
We excluded preoperative biopsy because early workup
revealed borderline high catecholamine levels that raised
the possibility of extra-adrenal pheochromocytoma, in
addition to the high vascularity of the mass. An endocri-
nologist and nephrologists were consulted preoperatively.
We requested a 131I-meta-iodobenzylguanidine whole
body scan to rule out extra-adrenal pheochromocytoma.
Metanephrine, vinyl mandelic acid and catecholamines
were within normal limits. Preoperative and intraopera-
tive precautions for possible diagnosis of extra-adrenal
pheochromocytoma were taken. Positron emission to-
mography was not considered because the course of the
disease over > 2 years was benign.
The patient underwent laparotomy. The mass was
found to be 10 cm × 10 cm and highly vascular. It occu-
pied the whole mesorectum, encroached on the sigmoid
mesentery and stretched the rectum in front of it.
Separation of the mass from the rectum was not possible,
therefore, traditional anterior resection was carried out
followed by reestablishment of bowel continuity by a pri-
mary stapled colorectal anastomosis (Figure 3). The
patient had a smooth postoperative course and was dis-
charged home on postoperative day 5 in good condition.
The pathology report came back as rectosigmoid
mesenteric Castleman’s disease, hyaline vascular type. The
bowel mucosa, submucosa and muscularis propria were
intact. Microscopy showed the attached mass to be
enlarged lymph nodes, showing diffuse follicles with
extensive vascular proliferation and hyalinisation of the
germinal centres and perifollicular areas (Figure 4A).
Plasma cells were seen focally (Figure 4B), but were all
polyclonal, as confirmed by immunohistochemical stain-
ing. The lesion was completely excised and no other
lymph node involvement was seen.
A B
Figure 2. (A, B) Magnetic resonance imaging revealed a large vascular mass (7 cm × 8 cm) superior to the urinary bladder and 
surrounding common iliac arteries.
Figure 1. Heterogeneous mass (6 cm × 7 cm) 2 years before
resection.
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HIV and HHV8 tests were negative. The patient was
readmitted 2 days after discharge with partial adhesive
intestinal obstruction that settled with conservative treat-
ment. The patient was followed up at 2 months and 
6 months without any problems.
Discussion
CD is a benign condition of unknown aetiology. It is a
lymphoproliferative disorder that has attracted attention
because of its association with HIV and HHV8, and several
malignancies including Kaposi’s sarcoma, non-Hodgkin’s
lymphoma, Hodgkin’s lymphoma and POEMS syndrome.
The histological findings can be divided into two types:
hyaline vascular and plasma cell types. The hyaline vascular
type accounts for > 90% of cases and is characterised by
small hyaline follicles and intrafollicular capillary prolif-
eration. The plasma cell type is less common and has 
A B
Figure 3. A specimen of recto-sigmoid mesenteric that was
excised following traditional anterior resection.
Figure 4. (A) Hyaline and vascular proliferation in and around the germinal centre. (B) High-power view of germinal centre with 
vascular proliferation in the centre.
a spreading arrangement of plasma cells in the involved
lymph nodes. Clinically, the hyaline vascular type is usually
asymptomatic, whereas patients with the plasma cell type
might present with systemic manifestations including
fever, anaemia, elevated C-reactive protein and erythrocyte
sedimentation rate, and hypergammaglobulinaemia.
A correct preoperative diagnosis of mesenteric CD was
not made; localised CD requires surgical removal of the
tumour for both diagnosis and therapy. Recurrence of the
localised disease is rare after complete surgical resection,
but it has been reported in patients with incomplete sur-
gical removal.2 Limited success with radiotherapy (30–45
Gy)4 and chemotherapy5 has been reported. It is generally
accepted that the disease is benign and surgery is cura-
tive.3 Complete surgical excision of the lesion after laparo-
tomy or even laparoscopic surgery is curative, and there
have been no reported cases of recurrence after total exci-
sion of a solitary mass.1
CD can be divided into two further forms: the more
common localised solitary form and the less frequent
multicentric form. Approximately 80% of the cases of the
solitary form belong to the hyaline vascular type and the
remaining 20% to the plasma cell type. The widespread
form of the disease is characterised by disseminated 
lymphadenopathy and is almost always associated with
systemic symptoms. The therapeutic approach for the
widespread form remains controversial because many
treatment regimens have been proposed including sur-
gery, chemotherapy, corticosteroids, or combinations 
of these. In most cases, diagnosis of mesenteric CD is 
confirmed only after resection and histopathological
examination of the specimen.
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